BIOL logo

BIOLASE (BIOL) EBITDA

Annual EBITDA

-$15.44 M
+$9.84 M+38.91%

December 31, 2023


Summary


Performance

BIOL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBIOLprofitabilitymetrics:

Quarterly EBITDA

-$97.00 K
+$1.45 M+93.71%

September 30, 2024


Summary


Performance

BIOL Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBIOLprofitabilitymetrics:

TTM EBITDA

-$10.90 M
+$3.32 M+23.35%

September 30, 2024


Summary


Performance

BIOL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBIOLprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

BIOL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+38.9%+97.2%+44.3%
3 y3 years-11.6%+97.2%+44.3%
5 y5 years+22.8%+97.2%+44.3%

BIOL EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+14.6%+63.7%at high+8338.1%at high+140.4%
5 y5-year+14.6%+63.7%-115.3%+8338.1%at high+140.4%
alltimeall time-310.8%+63.7%-103.6%+9449.5%-241.5%+140.4%

BIOLASE EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$97.00 K(-93.7%)
-$10.90 M(-23.3%)
Jun 2024
-
-$1.54 M(-70.3%)
-$14.21 M(-8.3%)
Mar 2024
-
-$5.18 M(+27.3%)
-$15.50 M(+0.4%)
Dec 2023
-$15.44 M(-38.9%)
-$4.07 M(+19.2%)
-$15.44 M(-21.0%)
Sep 2023
-
-$3.42 M(+20.7%)
-$19.55 M(-18.5%)
Jun 2023
-
-$2.83 M(-44.7%)
-$24.00 M(-8.4%)
Mar 2023
-
-$5.12 M(-37.4%)
-$26.19 M(+3.6%)
Dec 2022
-$25.28 M(+87.7%)
-$8.19 M(+4.2%)
-$25.28 M(+16.6%)
Sep 2022
-
-$7.86 M(+56.3%)
-$21.69 M(+32.1%)
Jun 2022
-
-$5.03 M(+19.5%)
-$16.42 M(+42.8%)
Mar 2022
-
-$4.21 M(-8.3%)
-$11.50 M(-14.6%)
Dec 2021
-$13.47 M(-2.7%)
-$4.59 M(+77.4%)
-$13.47 M(-6.2%)
Sep 2021
-
-$2.59 M(+2274.3%)
-$14.36 M(+28.9%)
Jun 2021
-
-$109.00 K(-98.2%)
-$11.14 M(-24.4%)
Mar 2021
-
-$6.18 M(+12.7%)
-$14.74 M(+6.7%)
Dec 2020
-$13.84 M(-6.2%)
-$5.49 M(-965.3%)
-$13.82 M(+23.3%)
Sep 2020
-
$634.00 K(-117.1%)
-$11.21 M(-32.2%)
Jun 2020
-
-$3.71 M(-29.5%)
-$16.52 M(+4.0%)
Mar 2020
-
-$5.26 M(+83.0%)
-$15.88 M(+7.5%)
Dec 2019
-$14.76 M(-26.2%)
-$2.87 M(-38.6%)
-$14.77 M(-18.8%)
Sep 2019
-
-$4.68 M(+52.3%)
-$18.18 M(+1.7%)
Jun 2019
-
-$3.07 M(-26.0%)
-$17.88 M(-8.0%)
Mar 2019
-
-$4.15 M(-34.0%)
-$19.43 M(-2.8%)
Dec 2018
-$20.00 M(+22.5%)
-$6.28 M(+43.5%)
-$20.00 M(+13.5%)
Sep 2018
-
-$4.38 M(-5.2%)
-$17.61 M(-0.4%)
Jun 2018
-
-$4.62 M(-2.0%)
-$17.68 M(+2.5%)
Mar 2018
-
-$4.71 M(+20.8%)
-$17.26 M(+5.7%)
Dec 2017
-$16.33 M(+17.4%)
-$3.90 M(-12.4%)
-$16.33 M(+0.4%)
Sep 2017
-
-$4.45 M(+6.2%)
-$16.27 M(+10.8%)
Jun 2017
-
-$4.19 M(+10.8%)
-$14.68 M(+8.0%)
Mar 2017
-
-$3.79 M(-1.5%)
-$13.60 M(-2.3%)
Dec 2016
-$13.91 M(-29.6%)
-$3.84 M(+34.3%)
-$13.91 M(+15.4%)
Sep 2016
-
-$2.86 M(-8.1%)
-$12.06 M(-15.6%)
Jun 2016
-
-$3.11 M(-24.1%)
-$14.28 M(-20.8%)
Mar 2016
-
-$4.10 M(+106.7%)
-$18.04 M(-8.8%)
Dec 2015
-$19.77 M(+14.6%)
-$1.98 M(-61.0%)
-$19.77 M(-7.1%)
Sep 2015
-
-$5.09 M(-25.9%)
-$21.27 M(+9.4%)
Jun 2015
-
-$6.86 M(+17.7%)
-$19.43 M(+4.4%)
Mar 2015
-
-$5.83 M(+67.3%)
-$18.62 M(+8.0%)
Dec 2014
-$17.25 M(+65.9%)
-$3.49 M(+7.2%)
-$17.25 M(+10.9%)
Sep 2014
-
-$3.25 M(-46.2%)
-$15.55 M(-2.8%)
Jun 2014
-
-$6.05 M(+35.7%)
-$16.00 M(+32.4%)
Mar 2014
-
-$4.46 M(+149.1%)
-$12.08 M(+16.2%)
Dec 2013
-$10.39 M(+374.0%)
-$1.79 M(-51.7%)
-$10.39 M(+42.2%)
Sep 2013
-
-$3.70 M(+73.9%)
-$7.31 M(+87.6%)
Jun 2013
-
-$2.13 M(-23.1%)
-$3.90 M(+13.0%)
Mar 2013
-
-$2.77 M(-314.1%)
-$3.45 M(+57.3%)
Dec 2012
-$2.19 M(-35.4%)
$1.29 M(-546.2%)
-$2.19 M(-59.2%)
Sep 2012
-
-$290.00 K(-82.8%)
-$5.38 M(-7.8%)
Jun 2012
-
-$1.68 M(+11.2%)
-$5.83 M(+24.1%)
Mar 2012
-
-$1.51 M(-19.8%)
-$4.70 M(+29.6%)
Dec 2011
-$3.40 M(-67.7%)
-$1.89 M(+154.1%)
-$3.62 M(+209.8%)
Sep 2011
-
-$743.00 K(+35.1%)
-$1.17 M(-56.8%)
Jun 2011
-
-$550.00 K(+24.7%)
-$2.71 M(-54.7%)
Mar 2011
-
-$441.00 K(-178.1%)
-$5.98 M(-43.2%)
Dec 2010
-$10.53 M(+688.9%)
$565.00 K(-124.8%)
-$10.53 M(-13.5%)
Sep 2010
-
-$2.28 M(-40.3%)
-$12.18 M(+40.3%)
Jun 2010
-
-$3.82 M(-23.4%)
-$8.68 M(+307.9%)
Mar 2010
-
-$4.99 M(+362.1%)
-$2.13 M(+59.4%)
Dec 2009
-$1.33 M(-80.8%)
-$1.08 M(-188.9%)
-$1.33 M(-73.2%)
Sep 2009
-
$1.22 M(-55.5%)
-$4.98 M(-50.8%)
Jun 2009
-
$2.73 M(-165.0%)
-$10.12 M(-15.5%)
Mar 2009
-
-$4.20 M(-11.2%)
-$11.98 M(+52.3%)
Dec 2008
-$6.94 M
-$4.73 M(+20.4%)
-$7.87 M(+49.3%)
Sep 2008
-
-$3.92 M(-553.8%)
-$5.27 M(+18.3%)
DateAnnualQuarterlyTTM
Jun 2008
-
$865.00 K(-1181.3%)
-$4.46 M(-22.7%)
Mar 2008
-
-$80.00 K(-96.2%)
-$5.77 M(-18.5%)
Dec 2007
-$7.08 M(+178.9%)
-$2.13 M(-31.5%)
-$7.08 M(+117.6%)
Sep 2007
-
-$3.11 M(+596.0%)
-$3.25 M(+294.5%)
Jun 2007
-
-$447.00 K(-67.8%)
-$824.00 K(-62.2%)
Mar 2007
-
-$1.39 M(-181.9%)
-$2.18 M(-14.1%)
Dec 2006
-$2.54 M(-83.9%)
$1.69 M(-347.7%)
-$2.54 M(-47.4%)
Sep 2006
-
-$684.00 K(-62.0%)
-$4.82 M(-46.6%)
Jun 2006
-
-$1.80 M(+3.3%)
-$9.02 M(-33.0%)
Mar 2006
-
-$1.75 M(+196.3%)
-$13.47 M(-14.5%)
Dec 2005
-$15.75 M(+81.8%)
-$589.00 K(-87.9%)
-$15.75 M(-35.5%)
Sep 2005
-
-$4.88 M(-21.9%)
-$24.42 M(+13.4%)
Jun 2005
-
-$6.25 M(+55.5%)
-$21.53 M(+54.7%)
Mar 2005
-
-$4.02 M(-56.6%)
-$13.92 M(+60.6%)
Dec 2004
-$8.66 M(-218.3%)
-$9.26 M(+364.8%)
-$8.66 M(-387.5%)
Sep 2004
-
-$1.99 M(-246.4%)
$3.01 M(-60.9%)
Jun 2004
-
$1.36 M(+10.6%)
$7.70 M(+1.2%)
Mar 2004
-
$1.23 M(-49.0%)
$7.61 M(+3.8%)
Dec 2003
$7.33 M(+341.9%)
$2.42 M(-10.3%)
$7.33 M(+38.1%)
Sep 2003
-
$2.69 M(+112.3%)
$5.30 M(+74.0%)
Jun 2003
-
$1.27 M(+33.3%)
$3.05 M(+26.5%)
Mar 2003
-
$951.00 K(+142.0%)
$2.41 M(+47.7%)
Dec 2002
$1.66 M(-267.0%)
$393.00 K(-10.1%)
$1.63 M(+89.3%)
Sep 2002
-
$437.00 K(-30.5%)
$862.00 K(+59.5%)
Jun 2002
-
$629.00 K(+263.6%)
$540.50 K(-406.2%)
Mar 2002
-
$173.00 K(-145.9%)
-$176.50 K(-82.2%)
Dec 2001
-$993.00 K(-71.4%)
-$377.00 K(-426.4%)
-$992.90 K(-13.0%)
Sep 2001
-
$115.50 K(-231.3%)
-$1.14 M(-51.6%)
Jun 2001
-
-$88.00 K(-86.3%)
-$2.36 M(-24.5%)
Mar 2001
-
-$643.40 K(+22.5%)
-$3.12 M(-10.0%)
Dec 2000
-$3.47 M(-25.2%)
-$525.40 K(-52.2%)
-$3.47 M(-30.4%)
Sep 2000
-
-$1.10 M(+29.0%)
-$4.98 M(+6.7%)
Jun 2000
-
-$852.50 K(-13.9%)
-$4.67 M(-6.8%)
Mar 2000
-
-$990.10 K(-51.5%)
-$5.01 M(+6.1%)
Dec 1999
-$4.64 M(-7.3%)
-$2.04 M(+159.2%)
-$4.72 M(+10.3%)
Sep 1999
-
-$787.20 K(-34.1%)
-$4.28 M(-12.5%)
Jun 1999
-
-$1.19 M(+70.5%)
-$4.89 M(-0.1%)
Mar 1999
-
-$700.00 K(-56.3%)
-$4.90 M(-2.0%)
Dec 1998
-$5.00 M(+78.6%)
-$1.60 M(+14.3%)
-$5.00 M(+19.0%)
Sep 1998
-
-$1.40 M(+16.7%)
-$4.20 M(+27.3%)
Jun 1998
-
-$1.20 M(+50.0%)
-$3.30 M(+13.8%)
Mar 1998
-
-$800.00 K(0.0%)
-$2.90 M(0.0%)
Dec 1997
-$2.80 M(+16.7%)
-$800.00 K(+60.0%)
-$2.90 M(0.0%)
Sep 1997
-
-$500.00 K(-37.5%)
-$2.90 M(-3.3%)
Jun 1997
-
-$800.00 K(0.0%)
-$3.00 M(+15.4%)
Mar 1997
-
-$800.00 K(0.0%)
-$2.60 M(+8.3%)
Dec 1996
-$2.40 M(+41.2%)
-$800.00 K(+33.3%)
-$2.40 M(+26.3%)
Sep 1996
-
-$600.00 K(+50.0%)
-$1.90 M(+26.7%)
Jun 1996
-
-$400.00 K(-33.3%)
-$1.50 M(0.0%)
Mar 1996
-
-$600.00 K(+100.0%)
-$1.50 M(-6.3%)
Dec 1995
-$1.70 M(-51.4%)
-$300.00 K(+50.0%)
-$1.60 M(-40.7%)
Sep 1995
-
-$200.00 K(-50.0%)
-$2.70 M(-18.2%)
Jun 1995
-
-$400.00 K(-42.9%)
-$3.30 M(0.0%)
Mar 1995
-
-$700.00 K(-50.0%)
-$3.30 M(+37.5%)
Dec 1994
-$3.50 M(-49.3%)
-$1.40 M(+75.0%)
-$2.40 M(-27.3%)
Sep 1994
-
-$800.00 K(+100.0%)
-$3.30 M(-15.4%)
Jun 1994
-
-$400.00 K(-300.0%)
-$3.90 M(-25.0%)
Mar 1994
-
$200.00 K(-108.7%)
-$5.20 M(-23.5%)
Dec 1993
-$6.90 M(+30.2%)
-$2.30 M(+64.3%)
-$6.80 M(0.0%)
Sep 1993
-
-$1.40 M(-17.6%)
-$6.80 M(+6.3%)
Jun 1993
-
-$1.70 M(+21.4%)
-$6.40 M(+8.5%)
Mar 1993
-
-$1.40 M(-39.1%)
-$5.90 M(+90.3%)
Dec 1992
-$5.30 M
-$2.30 M(+130.0%)
-$3.10 M(+287.5%)
Sep 1992
-
-$1.00 M(-16.7%)
-$800.00 K(-500.0%)
Jun 1992
-
-$1.20 M(-185.7%)
$200.00 K(-85.7%)
Mar 1992
-
$1.40 M
$1.40 M

FAQ

  • What is BIOLASE annual EBITDA?
  • What is the all time high annual EBITDA for BIOLASE?
  • What is BIOLASE annual EBITDA year-on-year change?
  • What is BIOLASE quarterly EBITDA?
  • What is the all time high quarterly EBITDA for BIOLASE?
  • What is BIOLASE quarterly EBITDA year-on-year change?
  • What is BIOLASE TTM EBITDA?
  • What is the all time high TTM EBITDA for BIOLASE?
  • What is BIOLASE TTM EBITDA year-on-year change?

What is BIOLASE annual EBITDA?

The current annual EBITDA of BIOL is -$15.44 M

What is the all time high annual EBITDA for BIOLASE?

BIOLASE all-time high annual EBITDA is $7.33 M

What is BIOLASE annual EBITDA year-on-year change?

Over the past year, BIOL annual EBITDA has changed by +$9.84 M (+38.91%)

What is BIOLASE quarterly EBITDA?

The current quarterly EBITDA of BIOL is -$97.00 K

What is the all time high quarterly EBITDA for BIOLASE?

BIOLASE all-time high quarterly EBITDA is $2.73 M

What is BIOLASE quarterly EBITDA year-on-year change?

Over the past year, BIOL quarterly EBITDA has changed by +$3.32 M (+97.16%)

What is BIOLASE TTM EBITDA?

The current TTM EBITDA of BIOL is -$10.90 M

What is the all time high TTM EBITDA for BIOLASE?

BIOLASE all-time high TTM EBITDA is $7.70 M

What is BIOLASE TTM EBITDA year-on-year change?

Over the past year, BIOL TTM EBITDA has changed by +$8.66 M (+44.27%)